期刊文献+

地佐辛复合依托咪酯用于全麻上腹部手术伴高血压患者的临床分析 被引量:7

Clinical analysis of application of dezocine combined with etomidate in patients with hypertension receiving upper abdominal surgery under general anesthesia
下载PDF
导出
摘要 目的:探讨地佐辛复合依托咪酯用于全麻上腹部手术伴高血压患者的临床效果。方法150例行上腹部手术合并高血压患者,随机分为两组。对照组应用芬太尼行全麻诱导,观察组应用地佐辛复合依托咪酯全麻诱导。结果观察组患者的血流动力学的稳定性优于对照组,差异具有统计学意义(P<0.01)。观察组在诱导期间阿托品使用率2.67%少于对照组10.67%,差异具有统计学意义(P<0.01)。观察组注射痛、肌阵挛和咳嗽反射等不良反应发生率少于对照组,差异具有统计学意义(P<0.01~0.05)。结论全麻上腹部手术伴高血压患者应用地佐辛复合依托咪酯麻醉能够促进患者血流动力学的稳定,降低诱导期间血管活性药物的使用量,且安全可靠。 Objective To explore the clinical effects of dezocine combined with etomidate for patients with hypertension receiving upper abdominal surgery under general anesthesia. Methods 150 patients with hypertension who received upper abdominal surgery were selected and randomly assigned to two groups.The control group received fentanyl for the general anesthesia induction and the observation group received dezocine combined with etomidate for the induction. Results Hemodynamic stability of the observation group was better than that of the control group, with statistically significant difference(P 〈 0.01).The application rate of atropine of the observation group during the induction was 2.67%, which was lower than the 10.67% of the control group, with statistically significant difference(P 〈 0.01).The incidences of adverse reactions such as injection pain, myoclonus and cough reflex of the observation group were lower than those of the control group,with statistically significant differences(P〈0.01-0.05). Conclusion The application of dezocine combined with etomidate in patients with hypertension receiving upper abdominal surgery under general anesthesia promotes hemodynamic stability, reduces the application amount of vasoactive drugs during induction, and is safe and reliable.
出处 《中国医药科学》 2014年第7期112-114,共3页 China Medicine And Pharmacy
关键词 上腹部手术 高血压 全麻诱导 地佐辛 依托咪酯 罗库溴铵 Upper abdominal surgery Hypertension General anesthesia Dezocine induction Etomidate Rocuronium bromide
  • 相关文献

参考文献10

二级参考文献52

共引文献153

同被引文献79

  • 1陈敏华,严昆,杨薇,高文,戴莹,王艳滨,张晖,霍苓,邢宝才,黄信孚.343例肝恶性肿瘤射频消融疗效及并发症[J].北京大学学报(医学版),2005,37(3):292-296. 被引量:64
  • 2林春水,卢刚,阮骆阳,古妙宁.舒芬太尼和芬太尼用于开胸术后病人自控静脉镇痛的比较研究[J].南方医科大学学报,2006,26(2):240-241. 被引量:40
  • 3Patel S.Cardiovascular effects of intravenous anesthetics.Int Anesthesiol Clin,2002,40(1):15-33.
  • 4Doenicke A,Roizen M,Kugler J,et al.Reducing myoclonus after etomidate.Anesthesiology,1999,90(1):113-119.
  • 5Kulka P,Bremer F,Schuttler J,et al.Anesthesia induction using etomidate in a lipid emulsion.Anaesthetist,1993,42(4):205-209.
  • 6Mizrak A,Koruk S,Bilgi M,et al.Pretreatment with dexmedetomidine or thiopental decreases myoclonus after etomidate:a randomized,double-blind controlled trial.J Surg Res,2010,159(1):e11-e16.
  • 7Ri H,Shin S,Kim T,et al.The proper effect site concentration of remifentanil for prevention of myoclonus after etomidate injection.Korean J Anesthesiol,2011,61(2):127-132.
  • 8Gultop F,Akkaya T,Bedirli N,et al.Lidocaine pretreatment reduces the frequency and severity of myoclonus induced by etomidate.J Anesth,2010,24(2):300-302.
  • 9He L,Ding Y,Chen H,et al.Dezocine pretreatment prevents myoclonus induced by etomidate:a randomized,double-blinded controlled trial.J Anesth,2015,29(1):143-145.
  • 10Hueter L,Schwarzkopf K,Simon M,et al.Pretreatment with sufentanil reduces myoclonus after etomidate.Acta Anaesthesiol Scand,2003,47(4):482-484.

引证文献7

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部